PT - JOURNAL ARTICLE AU - Duan, Haojing AU - Shi, Runye AU - Kang, Jujiao AU - Banaschewski, Tobias AU - Bokde, Arun L. W. AU - Büchel, Christian AU - Desrivières, Sylvane AU - Flor, Herta AU - Grigis, Antoine AU - Garavan, Hugh AU - Gowland, Penny A. AU - Heinz, Andreas AU - Brühl, Rüdiger AU - Martinot, Jean-Luc AU - Martinot, Marie-Laure Paillère AU - Artiges, Eric AU - Nees, Frauke AU - Papadopoulos Orfanos, Dimitri AU - Poustka, Luise AU - Hohmann, Sarah AU - Holz, Nathalie AU - Fröhner, Juliane H. AU - Smolka, Michael N. AU - Vaidya, Nilakshi AU - Walter, Henrik AU - Whelan, Robert AU - Schumann, Gunter AU - Lin, Xiaolei AU - Feng, Jianfeng AU - , TI - Population clustering of structural brain aging and its association with brain development AID - 10.1101/2024.01.09.24301030 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.09.24301030 4099 - http://medrxiv.org/content/early/2024/06/26/2024.01.09.24301030.short 4100 - http://medrxiv.org/content/early/2024/06/26/2024.01.09.24301030.full AB - Structural brain aging has demonstrated strong inter-individual heterogeneity and mirroring patterns with brain development. However, due to the lack of large-scale longitudinal neuroimaging studies, most of the existing research focused on the cross-sectional changes of brain aging. In this investigation, we present a data-driven approach that incorporate both cross-sectional changes and longitudinal trajectories of structural brain aging and identified two brain aging patterns among 37,013 healthy participants from UK Biobank. Participants with accelerated brain aging also demonstrated accelerated biological aging, cognitive decline and increased genetic susceptibilities to major neuropsychiatric disorders. Further, by integrating longitudinal neuroimaging studies from a multi-center adolescent cohort, we validated the “last in, first out” mirroring hypothesis and identified brain regions with manifested mirroring patterns between brain aging and brain development. Genomic analyses revealed risk loci and genes contributing to accelerated brain aging and delayed brain development, providing molecular basis for elucidating the biological mechanisms underlying brain aging and related disorders.Competing Interest StatementDr Banaschewski served in an advisory or consultancy role for eye level, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker's fee by Janssen, Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Dr Poustka served in an advisory or consultancy role for Roche and Viforpharm and received speaker's fee by Shire. She received royalties from Hogrefe, Kohlhammer and Schattauer. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.Funding StatementThis work received support from the following sources: National Key R&D Program of China (No.2019YFA0709502), National Key R&D Program of China (No.2018YFC1312904), Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01), ZJ Lab, and Shanghai Center for Brain Science and Brain-Inspired Technology, the 111 Project (No.B18015), the European Union-funded FP6 Integrated Project IMAGEN (Reinforcement-related behaviour in normal brain function and psychopathology) (LSHM-CT- 2007-037286), the Horizon 2020 funded ERC Advanced Grant 'STRATIFY' (Brain network based stratification of reinforcement-related disorders) (695313), Human Brain Project (HBP SGA 2, 785907, and HBP SGA 3, 945539), the Medical Research Council Grant 'c-VEDA' (Consortium on Vulnerability to Externalizing Disorders and Addictions) (MR/N000390/1), the National Institute of Health (NIH) (R01DA049238, A decentralized macro and micro gene-by-environment interaction analysis of substance use behavior and its brain biomarkers), the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, the Bundesministeriumfür Bildung und Forschung (BMBF grants 01GS08152; 01EV0711; Forschungsnetz AERIAL 01EE1406A, 01EE1406B; Forschungsnetz IMAC-Mind 01GL1745B), the Deutsche Forschungsgemeinschaft (DFG grants SM 80/7-2, SFB 940, TRR 265, NE 1383/14-1), the Medical Research Foundation and Medical Research Council (grants MR/R00465X/1 and MR/S020306/1), the National Institutes of Health (NIH) funded ENIGMA (grants 5U54EB020403-05 and 1R56AG058854-01), NSFC grant 82150710554 and European Union funded project 'environMENTAL', grant no: 101057429. Further support was provided by grants from: - the ANR (ANR-12-SAMA-0004, AAPG2019 - GeBra), the Eranet Neuron (AF12-NEUR0008-01 - WM2NA; and ANR-18-NEUR00002-01 - ADORe), the Fondation de France (00081242), the Fondation pour la Recherche Médicale (DPA20140629802), the Mission Interministérielle de Lutte-contre-les-Drogues-et-les-Conduites-Addictives (MILDECA), the Assistance-Publique-Hôpitaux-de-Paris and INSERM (interface grant), Paris Sud University IDEX 2012, the Fondation de l'Avenir (grant AP-RM-17-013 ), the Fédération pour la Recherche sur le Cerveau; the National Institutes of Health, Science Foundation Ireland (16/ERCD/3797), U.S.A. (Axon, Testosterone and Mental Health during Adolescence; RO1 MH085772-01A1) and by NIH Consortium grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centres of Excellence. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work used UK Biobank dataset, and its ethical approval was granted by the North West Multi-Center Ethics committee (https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics). The lMAGEN study was approved by local ethics research committees at each research site: King's College London, University of Nottingham. Trinity College Dublin, University of Heidelberg, Technische Universität; Dresden, Commissariat à l'énergie Atomique et aux énergies Alternatives, and University Medical Center.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll the UK Biobank data used in the study are available at https://www.ukbiobank.ac.uk. The IMAGEN project data are available at https://imagen-project.org. GWAS summary statistics used to calculate the PRS are available in the Supplementary Tables 9. Human gene expression data are available in the Allen Human Brain Atlas dataset: https://human.brainmap.org. https://www.ukbiobank.ac.uk https://imagen-project.org https://human.brainmap.org